Neuronal Nicotinic Receptors: UpdatesPlus March 2008

Questions: Discounts, Updates etc.

Price (Single): £5000

Price (Departmental): £5000

Price (Company): £5000

Publication Date: 2008-03-20

Order Online Now

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Providing a monthly detailed view and analysis of all key information from the exciting and rapidly expanding field of neuronal nicotinic receptors, UpdatesPlus-Nicotinic Receptors  is a must to all involved in CNS drug development. 

UpdatesPlus is available as a yearly subscription.  

See December 2007 edition now (free sample copy)

What's in the March 2008 edition of UpdatesPlus-Nicotinic Receptors?

The March 2008 edition of UpdatesPlus-Nicotinic Receptors reports on key events identified through tracking of:

This month, as usual we provide a fully up to date snapshot of the nicotinic receptor ligand pipeline.  In addition we report on the following:

 

 

  • Activity within Servier to develop alpha7 candidates with  beta amyloid blocking activity
  • Information on strategic refocusing withing Memory Pharmaceuticals and ongoing activity within the schizophrenia arena
  • Effects of alpha7 candidates on neuroinflammation - should clinical trials be looking at biomarkers of neuroinflammation?
  • Cardiovascular risk attached to the use of alpha7 agonists?
  • Targacept's movement towards the development of alpha4/beta2 candidates for treatment of the unmet market of refractory depression (including a Focus on Refractory depression section)
  • Prediction on clinical development of alpha6 candidates

    •  

     

    Pricing & Delivery:  UpdatesPlus is available on a subscription basis.  A one-off payment will get you the next twelve monthly editions of UpdatesPlus-Nicotinic Receptors plus access to all past editions.  UpdatesPlus is available for unlimited use within your company.  Delivered in a powerpoint format,  UpdatesPlus is both easy to use and also ready for use within a presentation setting

    2008 issues:

    About UpdatesPlus:  Through DailyUpdates, LeadDiscovery has access to one of the most comprehensive sources of information for the drug development sector.  UpdatesPlus takes this information and uses our industrial experience to provide a monthly analysis of breaking activity in selected indications and molecular targets.  If this is the first time that you have heard of UpdatesPlus please take a moment to have a look at an example.  If you would find such a service of use in your area contact us now.

     

     

    Other users found this report page using the following search terms: Neuronal Nicotinic Receptors nicotinic receptors alzheimer's amyloid depression alpha7 alpha6 alpha4beta2 pharmaceutical development alzheimers powerpoint alpha4beta2 nicotinic receptors ppt

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.